Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| chondrocyte | 4 studies | 58% ± 23% |
Insufficient scRNA-seq data for expression of ACAN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 67% | 197.75 | 60 / 89 | 65% | 9.32 | 586 / 901 |
| bladder | 71% | 136.57 | 15 / 21 | 50% | 1.70 | 251 / 504 |
| brain | 62% | 101.18 | 1629 / 2642 | 49% | 3.64 | 348 / 705 |
| stomach | 23% | 51.86 | 82 / 359 | 87% | 5.13 | 248 / 286 |
| lung | 69% | 312.00 | 401 / 578 | 37% | 1.07 | 430 / 1155 |
| intestine | 23% | 37.77 | 226 / 966 | 83% | 3.30 | 435 / 527 |
| blood vessel | 99% | 8513.79 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 68% | 132.05 | 445 / 653 | 29% | 0.76 | 176 / 605 |
| adrenal gland | 39% | 62.00 | 101 / 258 | 47% | 3.76 | 108 / 230 |
| esophagus | 17% | 28.85 | 249 / 1445 | 63% | 2.87 | 116 / 183 |
| uterus | 48% | 116.81 | 82 / 170 | 32% | 6.10 | 148 / 459 |
| breast | 31% | 57.31 | 142 / 459 | 47% | 5.58 | 528 / 1118 |
| skin | 42% | 147.53 | 759 / 1809 | 36% | 3.50 | 168 / 472 |
| prostate | 56% | 171.30 | 136 / 245 | 18% | 0.45 | 92 / 502 |
| ovary | 53% | 122.01 | 96 / 180 | 15% | 0.43 | 66 / 430 |
| pancreas | 12% | 20.42 | 39 / 328 | 52% | 1.32 | 92 / 178 |
| adipose | 58% | 197.52 | 696 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 43% | 48.88 | 104 / 241 | 0% | 0 | 0 / 0 |
| heart | 36% | 57.56 | 308 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 18% | 0.58 | 14 / 80 |
| liver | 1% | 1.38 | 2 / 226 | 17% | 0.53 | 67 / 406 |
| muscle | 16% | 24.52 | 129 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.26 | 7 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.03 | 1 / 29 |
| peripheral blood | 0% | 0.07 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
| GO_0010001 | Biological process | glial cell differentiation |
| GO_0007155 | Biological process | cell adhesion |
| GO_0006508 | Biological process | proteolysis |
| GO_0007417 | Biological process | central nervous system development |
| GO_0001501 | Biological process | skeletal system development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0045202 | Cellular component | synapse |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0072534 | Cellular component | perineuronal net |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| Gene name | ACAN |
| Protein name | Aggrecan Aggrecan core protein (Cartilage-specific proteoglycan core protein) Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2] |
| Synonyms | AGC1 MSK16 CSPG1 |
| Description | FUNCTION: This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region. |
| Accessions | H0YK70 ENST00000559004.5 [P16112-2] P16112 A0A5K1VW97 Q6PID9 ENST00000558704.1 ENST00000439576.7 [P16112-1] ENST00000561243.7 ENST00000558207.5 ENST00000352105.11 [P16112-3] H0YMF1 ENST00000560601.4 |